In vivo modulation of gap junctions and dye coupling between B-cells of the intact pancreatic islet

P. Meda, Robin L Michaels, P. A. Halban, L. Orci, J. D. Sheridan

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The extent of gap junctions and dye coupling between insulin-producing B-cells was analyzed on islets of Langerhans isolated from adult rats treated for one day with glibenclamide, an insulin secretagogue, or diazoxide, a blocker of insulin release, or a combination of the two drugs. Glibenclamide treatment was associated with a marked depletion of the islet insulin content, an effect which was blocked by pretreatment of the rats with diazoxide. Diazoxide alone caused a marked increase in the plasma glucose level, and a decrease in the level of circulating insulin and in the hormone content of the B-cells. Quantitative analysis showed that (1) under control conditions, B-cells are connected by minute gap junctions (as evaluated on freeze-fracture replicas) and show a nonuniform and apparently restricted dye coupling (as determined by microinjection of the low-molecular-weight fluorescent probe Lucifer Yellow CH); (2) each of the 3 treatments tested significantly increased the relative and absolute gap junction area of the B-cells and the number of detectable, dye coupled B-cells per microinjection. After treatment with glibenclamide alone or with diazoxide plus glibenclamide, a 1.5-1.8-fold increase in gap junction area and a 2.7-3.7-fold increase in the number of dye-coupled B-cells were observed. In contrast, following treatment with diazoxide alone, gap junctions and dye coupling were found increased 1.8 and 8.7 times, respectively, as compared with control values. The results suggest that small territories of coupled B-cells may exist within adult islets of Langerhans, and show that such a pattern can be modulated in vivo via changes in the gap junctions and dye coupling of B-cells. The mechanism(s) regulating these changes is unknown but is clearly operative after both stimulation and inhibition of insulin release.

Original languageEnglish (US)
Pages (from-to)858-868
Number of pages11
JournalUnknown Journal
Volume32
Issue number9
DOIs
StatePublished - Jan 1 1983

Fingerprint

Gap Junctions
Islets of Langerhans
Insulin
Diazoxide
B-Lymphocytes
Coloring Agents
Dyes
Cells
Modulation
Glyburide
Microinjections
Rats
Hormones
Drug Combinations
Therapeutics
Fluorescent Dyes
Glucose
Cell Count
Molecular Weight
Molecular weight

Cite this

In vivo modulation of gap junctions and dye coupling between B-cells of the intact pancreatic islet. / Meda, P.; Michaels, Robin L; Halban, P. A.; Orci, L.; Sheridan, J. D.

In: Unknown Journal, Vol. 32, No. 9, 01.01.1983, p. 858-868.

Research output: Contribution to journalArticle

Meda, P. ; Michaels, Robin L ; Halban, P. A. ; Orci, L. ; Sheridan, J. D. / In vivo modulation of gap junctions and dye coupling between B-cells of the intact pancreatic islet. In: Unknown Journal. 1983 ; Vol. 32, No. 9. pp. 858-868.
@article{5c80d498b4b1445991f89e1cf10495ef,
title = "In vivo modulation of gap junctions and dye coupling between B-cells of the intact pancreatic islet",
abstract = "The extent of gap junctions and dye coupling between insulin-producing B-cells was analyzed on islets of Langerhans isolated from adult rats treated for one day with glibenclamide, an insulin secretagogue, or diazoxide, a blocker of insulin release, or a combination of the two drugs. Glibenclamide treatment was associated with a marked depletion of the islet insulin content, an effect which was blocked by pretreatment of the rats with diazoxide. Diazoxide alone caused a marked increase in the plasma glucose level, and a decrease in the level of circulating insulin and in the hormone content of the B-cells. Quantitative analysis showed that (1) under control conditions, B-cells are connected by minute gap junctions (as evaluated on freeze-fracture replicas) and show a nonuniform and apparently restricted dye coupling (as determined by microinjection of the low-molecular-weight fluorescent probe Lucifer Yellow CH); (2) each of the 3 treatments tested significantly increased the relative and absolute gap junction area of the B-cells and the number of detectable, dye coupled B-cells per microinjection. After treatment with glibenclamide alone or with diazoxide plus glibenclamide, a 1.5-1.8-fold increase in gap junction area and a 2.7-3.7-fold increase in the number of dye-coupled B-cells were observed. In contrast, following treatment with diazoxide alone, gap junctions and dye coupling were found increased 1.8 and 8.7 times, respectively, as compared with control values. The results suggest that small territories of coupled B-cells may exist within adult islets of Langerhans, and show that such a pattern can be modulated in vivo via changes in the gap junctions and dye coupling of B-cells. The mechanism(s) regulating these changes is unknown but is clearly operative after both stimulation and inhibition of insulin release.",
author = "P. Meda and Michaels, {Robin L} and Halban, {P. A.} and L. Orci and Sheridan, {J. D.}",
year = "1983",
month = "1",
day = "1",
doi = "10.2337/diab.32.9.858",
language = "English (US)",
volume = "32",
pages = "858--868",
journal = "Journal of Fluid Mechanics",
issn = "0022-1120",
publisher = "Cambridge University Press",
number = "9",

}

TY - JOUR

T1 - In vivo modulation of gap junctions and dye coupling between B-cells of the intact pancreatic islet

AU - Meda, P.

AU - Michaels, Robin L

AU - Halban, P. A.

AU - Orci, L.

AU - Sheridan, J. D.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - The extent of gap junctions and dye coupling between insulin-producing B-cells was analyzed on islets of Langerhans isolated from adult rats treated for one day with glibenclamide, an insulin secretagogue, or diazoxide, a blocker of insulin release, or a combination of the two drugs. Glibenclamide treatment was associated with a marked depletion of the islet insulin content, an effect which was blocked by pretreatment of the rats with diazoxide. Diazoxide alone caused a marked increase in the plasma glucose level, and a decrease in the level of circulating insulin and in the hormone content of the B-cells. Quantitative analysis showed that (1) under control conditions, B-cells are connected by minute gap junctions (as evaluated on freeze-fracture replicas) and show a nonuniform and apparently restricted dye coupling (as determined by microinjection of the low-molecular-weight fluorescent probe Lucifer Yellow CH); (2) each of the 3 treatments tested significantly increased the relative and absolute gap junction area of the B-cells and the number of detectable, dye coupled B-cells per microinjection. After treatment with glibenclamide alone or with diazoxide plus glibenclamide, a 1.5-1.8-fold increase in gap junction area and a 2.7-3.7-fold increase in the number of dye-coupled B-cells were observed. In contrast, following treatment with diazoxide alone, gap junctions and dye coupling were found increased 1.8 and 8.7 times, respectively, as compared with control values. The results suggest that small territories of coupled B-cells may exist within adult islets of Langerhans, and show that such a pattern can be modulated in vivo via changes in the gap junctions and dye coupling of B-cells. The mechanism(s) regulating these changes is unknown but is clearly operative after both stimulation and inhibition of insulin release.

AB - The extent of gap junctions and dye coupling between insulin-producing B-cells was analyzed on islets of Langerhans isolated from adult rats treated for one day with glibenclamide, an insulin secretagogue, or diazoxide, a blocker of insulin release, or a combination of the two drugs. Glibenclamide treatment was associated with a marked depletion of the islet insulin content, an effect which was blocked by pretreatment of the rats with diazoxide. Diazoxide alone caused a marked increase in the plasma glucose level, and a decrease in the level of circulating insulin and in the hormone content of the B-cells. Quantitative analysis showed that (1) under control conditions, B-cells are connected by minute gap junctions (as evaluated on freeze-fracture replicas) and show a nonuniform and apparently restricted dye coupling (as determined by microinjection of the low-molecular-weight fluorescent probe Lucifer Yellow CH); (2) each of the 3 treatments tested significantly increased the relative and absolute gap junction area of the B-cells and the number of detectable, dye coupled B-cells per microinjection. After treatment with glibenclamide alone or with diazoxide plus glibenclamide, a 1.5-1.8-fold increase in gap junction area and a 2.7-3.7-fold increase in the number of dye-coupled B-cells were observed. In contrast, following treatment with diazoxide alone, gap junctions and dye coupling were found increased 1.8 and 8.7 times, respectively, as compared with control values. The results suggest that small territories of coupled B-cells may exist within adult islets of Langerhans, and show that such a pattern can be modulated in vivo via changes in the gap junctions and dye coupling of B-cells. The mechanism(s) regulating these changes is unknown but is clearly operative after both stimulation and inhibition of insulin release.

UR - http://www.scopus.com/inward/record.url?scp=0020513139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020513139&partnerID=8YFLogxK

U2 - 10.2337/diab.32.9.858

DO - 10.2337/diab.32.9.858

M3 - Article

C2 - 6414863

AN - SCOPUS:0020513139

VL - 32

SP - 858

EP - 868

JO - Journal of Fluid Mechanics

JF - Journal of Fluid Mechanics

SN - 0022-1120

IS - 9

ER -